{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05934253",
            "orgStudyIdInfo": {
                "id": "IZ-4-001"
            },
            "organization": {
                "fullName": "Harrow Inc",
                "class": "INDUSTRY"
            },
            "briefTitle": "The Effects of Low Viscosity Chloroprocaine Ophthalmic Gel 3% on the Bactericidal Action of Povidone-Iodine",
            "officialTitle": "The Effects of Low Viscosity Chloroprocaine Ophthalmic Gel 3% on the Bactericidal Action of Povidone-Iodine: A Comparison vs Tetracaine 0.5% Solution.",
            "therapeuticArea": [
                "Other"
            ],
            "study": "the-effects-of-low-viscosity-chloroprocaine-ophthalmic-gel-on-the-bactericidal-action-of-povidone-iodine"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-09",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-07-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-01-15",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-02-15",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-06-09",
            "studyFirstSubmitQcDate": "2023-06-28",
            "studyFirstPostDateStruct": {
                "date": "2023-07-06",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-09-20",
            "lastUpdatePostDateStruct": {
                "date": "2023-09-21",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Harrow Inc",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "To evaluate if Iheezo's (chloroprocaine 3%) gel vehicle acts as a barrier on the ocular surface, potentially blocking the bactericidal action of povidone-iodine.",
            "detailedDescription": "Choice in vehicle plays a large role in drug delivery with topical ophthalmic medications. One strategy to increase efficacy is by increasing the ocular surface contact time of a drug on the eye, primarily by increasing the viscosity of the vehicle. However, studies have demonstrated that high viscosity topical medications act as a barrier to subsequent drops. This poses a serious issue in pre-operative prophylaxis, as high viscosity vehicles may block the bactericidal action of povidone-iodine. This has been supported by in vitro studies of Akten (lidocaine 3.5%) gel.\n\nAkten gel has a viscosity between 4000-9000 cps. Iheezo has a viscosity between 1200-2000 cps. Generic tetracaine 0.5% has a viscosity between 15-25cps. Healthy human tears have a viscosity of around 8 cps. For a vehicle to not act as a barrier to subsequent drops, it is believed that the viscosity should be close to human tears.\n\nThis study theorizes that Iheezo's lower viscosity will not act as a barrier to the bactericidal action of Povidone-iodine 5%.\n\nThis is a single site, prospective, randomized, patient masked, open-label study evaluating the effects of Iheezo (chloroprocaine HCl ophthalmic gel 3%) and how it may interact with povidone-iodine compared to tetracaine 0.5% ophthalmic solution. Consented patients will have their eyes randomized, one receiving Iheezo and the other tetracaine 0.5% ophthalmic solution."
        },
        "conditionsModule": {
            "conditions": [
                "Antiseptic",
                "Anesthesia, Local"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Chloroprocaine ophthalmic gel 3%",
                    "type": "EXPERIMENTAL",
                    "description": "FDA approved topical ophthalmic anesthetic applied 3 drops to the ocular surface before the planned procedure.",
                    "interventionNames": [
                        "Drug: Chloroprocaine ophthalmic gel 3%"
                    ]
                },
                {
                    "label": "Tetracaine ophthalmic solution 0.5%",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "FDA approved topical ophthalmic anesthetic applied 3 drops to the ocular surface before the planned procedure.",
                    "interventionNames": [
                        "Drug: Chloroprocaine ophthalmic gel 3%"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Chloroprocaine ophthalmic gel 3%",
                    "description": "FDA approved topical ophthalmic anesthetic applied 3 drops to the ocular surface before the planned procedure.",
                    "armGroupLabels": [
                        "Chloroprocaine ophthalmic gel 3%",
                        "Tetracaine ophthalmic solution 0.5%"
                    ],
                    "otherNames": [
                        "Iheezo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in colony forming units",
                    "description": "Comparison of results from Bacterial Culture Swabs before and after application of drug and povidone-iodine. First bacterial culture at initiation. Study medication applied after culture. Povidone-iodine applied two minutes after. Second bacterial culture three minutes after.",
                    "timeFrame": "Baseline and 5 minutes after baseline."
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients over age 18.\n* Able to comprehend and sign a statement of informed consent.\n\nExclusion Criteria:\n\n* Ocular surgery (e.g., intraocular, oculoplastic, corneal, or refractive surgical procedure) performed within the last 3 months or at any time that in the investigator's clinical judgment if it would interfere with the outcome measures of this study.\n* Clinically significant ocular trauma.\n* Diagnosis of lagophthalmos, or other severe eyelid abnormalities (entropion, ectropion, tumor, edema, blepharospasm, severe trichiasis, severe ptosis.)\n* Active ocular inflammation (uveitis, iritis, scleritis, episcleritis, keratitis, conjunctivitis) at the discretion of the investigator.\n* Active ocular infection (e.g., viral, bacterial, mycobacterial, protozoan or fungal infection or the cornea, conjunctiva, lacrimal gland, lacrimal sac or eyelids including hordeolum/stye).\n* Ocular infection within the last 3 months.\n* Moderate to severe (Grade 2-4) allergic, vernal or giant papillary conjunctivitis.\n* Patients who are under age 18, pregnant or breastfeeding, or who may become pregnant during participation in the study.\n* Monocular patients.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "genderBased": true,
            "minimumAge": "18 Years",
            "maximumAge": "99 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Richard Costine, PharmD",
                    "role": "CONTACT",
                    "phone": "8505097474",
                    "email": "rcostine@harrowinc.com"
                }
            ],
            "locations": [
                {
                    "facility": "Brandon Eye Associates",
                    "status": "RECRUITING",
                    "city": "Brandon",
                    "state": "Florida",
                    "zip": "33511",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Michelle Fleshner",
                            "role": "CONTACT",
                            "email": "michelle_fleshner@yahoo.com"
                        },
                        {
                            "name": "Haroon Ilyas, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 27.9378,
                        "lon": -82.28592
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000004616",
                    "term": "Chloroprocaine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000779",
                    "term": "Anesthetics, Local"
                },
                {
                    "id": "D000000777",
                    "term": "Anesthetics"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4107",
                    "name": "Anesthetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M12814",
                    "name": "Ophthalmic Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M10488",
                    "name": "Iodine",
                    "relevance": "LOW"
                },
                {
                    "id": "M232383",
                    "name": "Chloroprocaine",
                    "asFound": "ER+",
                    "relevance": "HIGH"
                },
                {
                    "id": "M229695",
                    "name": "Cadexomer iodine",
                    "relevance": "LOW"
                },
                {
                    "id": "M14088",
                    "name": "Povidone-Iodine",
                    "relevance": "LOW"
                },
                {
                    "id": "M14087",
                    "name": "Povidone",
                    "relevance": "LOW"
                },
                {
                    "id": "M16517",
                    "name": "Tetracaine",
                    "relevance": "LOW"
                },
                {
                    "id": "M4109",
                    "name": "Anesthetics, Local",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "Micro",
                    "name": "Micronutrients"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "BlSubst",
                    "name": "Blood Substitutes"
                }
            ]
        }
    },
    "hasResults": false
}